HCA Healthcare, Inc. (HCA) Options Risk Score

Run a full HCA options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on HCA Healthcare, Inc. (HCA) right now?

Over a 4-week expiry window, HCA Healthcare, Inc. (HCA) scores 100 out of 100 for options catalyst risk (HIGH). The contributing signals are an upcoming earnings report, 7 recent news items, 10 active legal filings and 66 clinical-trial catalysts within the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on HCA is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.

HCA shows an IV Rank of 43, near the low end of its one-year range — options are relatively cheap, which favours option buyers over sellers, with a current implied volatility of about 38%. IV Rank is the most useful figure for deciding whether to sell or buy premium on HCA.

The 2026-10-23 earnings report sits inside a standard monthly expiry for HCA, so implied volatility should stay bid into the date and drop sharply once it passes.

HCA Healthcare, Inc. (HCA) current implied volatility and IV Rank

The most recent read on HCA Healthcare, Inc. (HCA) puts its IV Rank at 43 with implied volatility around 38%, alongside a TickerRisk options-risk score of 100/100. That is roughly mid-range for this stock, meaning implied volatility offers neither a clear selling edge nor a bargain. Directional conviction matters more than vol here.

For what this number does and does not tell you about HCA's options, see IV Rank explained.

HCA Healthcare, Inc. (HCA) next earnings date — 2026-10-23

HCA Healthcare, Inc. (HCA) reports earnings on 2026-10-23 — about 45 days away, which falls inside a typical options expiry window. HCA's IV Rank is currently 43. Earnings are the single biggest scheduled catalyst for an overnight gap: implied volatility usually runs up into the report and collapses immediately after (the IV crush). Selling premium into the event captures that crush but exposes you to the gap; buying premium needs a move large enough to beat the elevated IV you paid.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer